

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.36947829 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.36947829 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.08646204 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.08646204 |
| 5 | proteasome assembly (GO:0043248) | 5.74272578 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 5.62563653 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 4.97667787 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 4.97667787 |
| 9 | tryptophan catabolic process (GO:0006569) | 4.97667787 |
| 10 | protein neddylation (GO:0045116) | 4.84001469 |
| 11 | cullin deneddylation (GO:0010388) | 4.82843494 |
| 12 | tryptophan metabolic process (GO:0006568) | 4.80863187 |
| 13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.79976323 |
| 14 | bile acid biosynthetic process (GO:0006699) | 4.67181201 |
| 15 | protein carboxylation (GO:0018214) | 4.62717658 |
| 16 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.62717658 |
| 17 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.57729198 |
| 18 | protein deneddylation (GO:0000338) | 4.51248937 |
| 19 | kynurenine metabolic process (GO:0070189) | 4.43682159 |
| 20 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.42068069 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 4.40765067 |
| 22 | glyoxylate metabolic process (GO:0046487) | 4.35852133 |
| 23 | complement activation, alternative pathway (GO:0006957) | 4.28035626 |
| 24 | platelet dense granule organization (GO:0060155) | 4.23398914 |
| 25 | regulation of cholesterol esterification (GO:0010872) | 4.23107561 |
| 26 | alpha-linolenic acid metabolic process (GO:0036109) | 4.21519537 |
| 27 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.20421351 |
| 28 | DNA double-strand break processing (GO:0000729) | 4.19792023 |
| 29 | aldehyde catabolic process (GO:0046185) | 4.18690151 |
| 30 | aromatic amino acid family metabolic process (GO:0009072) | 4.16171578 |
| 31 | DNA deamination (GO:0045006) | 4.16000885 |
| 32 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.12104171 |
| 33 | sulfur amino acid catabolic process (GO:0000098) | 4.11115802 |
| 34 | urea cycle (GO:0000050) | 4.10743903 |
| 35 | urea metabolic process (GO:0019627) | 4.10743903 |
| 36 | cysteine metabolic process (GO:0006534) | 4.10680631 |
| 37 | negative regulation of fibrinolysis (GO:0051918) | 4.07696715 |
| 38 | tyrosine metabolic process (GO:0006570) | 4.05503998 |
| 39 | reverse cholesterol transport (GO:0043691) | 4.00458338 |
| 40 | phospholipid efflux (GO:0033700) | 3.99555964 |
| 41 | bile acid metabolic process (GO:0008206) | 3.99400611 |
| 42 | regulation of protein activation cascade (GO:2000257) | 3.99372070 |
| 43 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.98832083 |
| 44 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.97856953 |
| 45 | regulation of fibrinolysis (GO:0051917) | 3.97787047 |
| 46 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.97604567 |
| 47 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.97017321 |
| 48 | negative regulation of ligase activity (GO:0051352) | 3.97017321 |
| 49 | chromatin remodeling at centromere (GO:0031055) | 3.96103467 |
| 50 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.94508931 |
| 51 | respiratory chain complex IV assembly (GO:0008535) | 3.93123378 |
| 52 | protein-lipid complex remodeling (GO:0034368) | 3.92284080 |
| 53 | macromolecular complex remodeling (GO:0034367) | 3.92284080 |
| 54 | plasma lipoprotein particle remodeling (GO:0034369) | 3.92284080 |
| 55 | chaperone-mediated protein transport (GO:0072321) | 3.92272986 |
| 56 | CENP-A containing nucleosome assembly (GO:0034080) | 3.85994066 |
| 57 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.84143008 |
| 58 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.83290572 |
| 59 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.82885341 |
| 60 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.82364217 |
| 61 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.82364217 |
| 62 | nitrogen cycle metabolic process (GO:0071941) | 3.81258690 |
| 63 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.76024139 |
| 64 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.76024139 |
| 65 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.76024139 |
| 66 | amine catabolic process (GO:0009310) | 3.74740307 |
| 67 | cellular biogenic amine catabolic process (GO:0042402) | 3.74740307 |
| 68 | regulation of complement activation (GO:0030449) | 3.74728221 |
| 69 | low-density lipoprotein particle remodeling (GO:0034374) | 3.73188704 |
| 70 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.72785413 |
| 71 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.72785413 |
| 72 | indolalkylamine metabolic process (GO:0006586) | 3.72673332 |
| 73 | homocysteine metabolic process (GO:0050667) | 3.70839447 |
| 74 | triglyceride homeostasis (GO:0070328) | 3.70790129 |
| 75 | acylglycerol homeostasis (GO:0055090) | 3.70790129 |
| 76 | signal peptide processing (GO:0006465) | 3.69465718 |
| 77 | cholesterol efflux (GO:0033344) | 3.68425759 |
| 78 | rRNA modification (GO:0000154) | 3.65010492 |
| 79 | regulation of triglyceride catabolic process (GO:0010896) | 3.63684134 |
| 80 | serine family amino acid catabolic process (GO:0009071) | 3.63223829 |
| 81 | plasma lipoprotein particle clearance (GO:0034381) | 3.63158490 |
| 82 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 3.60400981 |
| 83 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.58594790 |
| 84 | coenzyme catabolic process (GO:0009109) | 3.57731640 |
| 85 | cofactor catabolic process (GO:0051187) | 3.57197944 |
| 86 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.55516102 |
| 87 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.55516102 |
| 88 | ribosome assembly (GO:0042255) | 3.53598488 |
| 89 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.49286003 |
| 90 | histone mRNA metabolic process (GO:0008334) | 3.47116776 |
| 91 | alpha-amino acid catabolic process (GO:1901606) | 3.46296978 |
| 92 | bile acid and bile salt transport (GO:0015721) | 3.46022384 |
| 93 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.44988537 |
| 94 | DNA damage response, detection of DNA damage (GO:0042769) | 3.43757895 |
| 95 | cytochrome complex assembly (GO:0017004) | 3.41398610 |
| 96 | maturation of 5.8S rRNA (GO:0000460) | 3.40742618 |
| 97 | protein complex biogenesis (GO:0070271) | 3.40056914 |
| 98 | cellular glucuronidation (GO:0052695) | 3.38259817 |
| 99 | replication fork processing (GO:0031297) | 3.36441052 |
| 100 | amino-acid betaine metabolic process (GO:0006577) | 3.35909836 |
| 101 | histone exchange (GO:0043486) | 3.35894724 |
| 102 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.35780811 |
| 103 | positive regulation of ligase activity (GO:0051351) | 3.35327751 |
| 104 | plasma lipoprotein particle assembly (GO:0034377) | 3.34861338 |
| 105 | glucuronate metabolic process (GO:0019585) | 3.34576051 |
| 106 | uronic acid metabolic process (GO:0006063) | 3.34576051 |
| 107 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.34295245 |
| 108 | response to pheromone (GO:0019236) | 3.30690432 |
| 109 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.29607847 |
| 110 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.29607847 |
| 111 | imidazole-containing compound metabolic process (GO:0052803) | 3.28623935 |
| 112 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.27149435 |
| 113 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.27149435 |
| 114 | ATP synthesis coupled proton transport (GO:0015986) | 3.26872326 |
| 115 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.26872326 |
| 116 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.26391199 |
| 117 | benzene-containing compound metabolic process (GO:0042537) | 3.26167174 |
| 118 | plasma lipoprotein particle organization (GO:0071827) | 3.22637590 |
| 119 | negative regulation of cholesterol transport (GO:0032375) | 3.21652486 |
| 120 | negative regulation of sterol transport (GO:0032372) | 3.21652486 |
| 121 | short-chain fatty acid metabolic process (GO:0046459) | 3.21174296 |
| 122 | cellular amino acid catabolic process (GO:0009063) | 3.20732632 |
| 123 | termination of RNA polymerase III transcription (GO:0006386) | 3.19371044 |
| 124 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.19371044 |
| 125 | intestinal cholesterol absorption (GO:0030299) | 3.19308925 |
| 126 | NAD biosynthetic process (GO:0009435) | 3.19086361 |
| 127 | fibrinolysis (GO:0042730) | 3.18894637 |
| 128 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.18365381 |
| 129 | NADH dehydrogenase complex assembly (GO:0010257) | 3.18365381 |
| 130 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.18365381 |
| 131 | establishment of integrated proviral latency (GO:0075713) | 3.17769631 |
| 132 | rRNA methylation (GO:0031167) | 3.15911736 |
| 133 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.14707716 |
| 134 | complement activation, classical pathway (GO:0006958) | 3.10505893 |
| 135 | phospholipid homeostasis (GO:0055091) | 3.10202902 |
| 136 | serine family amino acid metabolic process (GO:0009069) | 3.09864218 |
| 137 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.09736369 |
| 138 | lipoprotein metabolic process (GO:0042157) | 3.09334848 |
| 139 | complement activation (GO:0006956) | 3.07810154 |
| 140 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.07599518 |
| 141 | valine metabolic process (GO:0006573) | 3.06855816 |
| 142 | protein activation cascade (GO:0072376) | 3.06244538 |
| 143 | Golgi transport vesicle coating (GO:0048200) | 3.06080521 |
| 144 | COPI coating of Golgi vesicle (GO:0048205) | 3.06080521 |
| 145 | cholesterol homeostasis (GO:0042632) | 3.05486336 |
| 146 | glycine metabolic process (GO:0006544) | 3.04992691 |
| 147 | regulation of ligase activity (GO:0051340) | 3.04452487 |
| 148 | cellular modified amino acid catabolic process (GO:0042219) | 3.04127669 |
| 149 | cellular ketone body metabolic process (GO:0046950) | 3.03982387 |
| 150 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 3.02797739 |
| 151 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 3.02797739 |
| 152 | isotype switching (GO:0045190) | 3.02797739 |
| 153 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 3.02513403 |
| 154 | metaphase plate congression (GO:0051310) | 3.02215865 |
| 155 | serine family amino acid biosynthetic process (GO:0009070) | 3.01982724 |
| 156 | sterol homeostasis (GO:0055092) | 3.00467116 |
| 157 | carboxylic acid catabolic process (GO:0046395) | 3.00312090 |
| 158 | organic acid catabolic process (GO:0016054) | 3.00312090 |
| 159 | DNA ligation (GO:0006266) | 2.99769363 |
| 160 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.99383051 |
| 161 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.99383051 |
| 162 | regulation of helicase activity (GO:0051095) | 2.98908589 |
| 163 | protein-cofactor linkage (GO:0018065) | 2.98381539 |
| 164 | opsonization (GO:0008228) | 2.97937920 |
| 165 | fatty acid beta-oxidation (GO:0006635) | 2.97880302 |
| 166 | protein-lipid complex subunit organization (GO:0071825) | 2.97721072 |
| 167 | mitotic metaphase plate congression (GO:0007080) | 2.97542848 |
| 168 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.96024354 |
| 169 | nucleotide transmembrane transport (GO:1901679) | 2.94355635 |
| 170 | blood coagulation, intrinsic pathway (GO:0007597) | 2.93890063 |
| 171 | drug transmembrane transport (GO:0006855) | 2.93699582 |
| 172 | response to X-ray (GO:0010165) | 2.92886959 |
| 173 | fatty acid oxidation (GO:0019395) | 2.91338894 |
| 174 | spindle checkpoint (GO:0031577) | 2.90756948 |
| 175 | protein-lipid complex assembly (GO:0065005) | 2.90591364 |
| 176 | acute-phase response (GO:0006953) | 2.90133375 |
| 177 | protein K6-linked ubiquitination (GO:0085020) | 2.89556137 |
| 178 | respiratory electron transport chain (GO:0022904) | 2.88989803 |
| 179 | negative regulation of protein ubiquitination (GO:0031397) | 2.88187438 |
| 180 | DNA replication checkpoint (GO:0000076) | 2.87856398 |
| 181 | protein K11-linked ubiquitination (GO:0070979) | 2.87321920 |
| 182 | electron transport chain (GO:0022900) | 2.85947112 |
| 183 | kinetochore assembly (GO:0051382) | 2.85317511 |
| 184 | recombinational repair (GO:0000725) | 2.84050849 |
| 185 | kinetochore organization (GO:0051383) | 2.83205746 |
| 186 | mitotic spindle checkpoint (GO:0071174) | 2.82019963 |
| 187 | double-strand break repair via homologous recombination (GO:0000724) | 2.81626392 |
| 188 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.79592842 |
| 189 | spliceosomal snRNP assembly (GO:0000387) | 2.78529053 |
| 190 | pseudouridine synthesis (GO:0001522) | 2.78291093 |
| 191 | purine nucleobase biosynthetic process (GO:0009113) | 2.77118991 |
| 192 | positive regulation of cell cycle arrest (GO:0071158) | 2.75423148 |
| 193 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.75375601 |
| 194 | DNA replication-independent nucleosome organization (GO:0034724) | 2.74835884 |
| 195 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.74835884 |
| 196 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.74259642 |
| 197 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.74259642 |
| 198 | regulation of cellular amine metabolic process (GO:0033238) | 2.73832781 |
| 199 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.71171259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.45110099 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.16057188 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.85421542 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.29658264 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.85649131 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.79365307 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.98222217 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.95835920 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.90975871 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.46441883 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.25994335 |
| 12 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.87359128 |
| 13 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.81867143 |
| 14 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.57054791 |
| 15 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.47753683 |
| 16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.43670613 |
| 17 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.39758615 |
| 18 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.37718851 |
| 19 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.36921116 |
| 20 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.34728701 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.32226477 |
| 22 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.31580614 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.27284663 |
| 24 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.24521815 |
| 25 | VDR_22108803_ChIP-Seq_LS180_Human | 2.18619877 |
| 26 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.17742008 |
| 27 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.17082902 |
| 28 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.16286073 |
| 29 | EWS_26573619_Chip-Seq_HEK293_Human | 2.14336061 |
| 30 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.04443542 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.02589655 |
| 32 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.01999428 |
| 33 | FUS_26573619_Chip-Seq_HEK293_Human | 1.98440511 |
| 34 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.95885452 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.93521241 |
| 36 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.92880240 |
| 37 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.88360651 |
| 38 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.88031824 |
| 39 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.87757364 |
| 40 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.86404009 |
| 41 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.86358474 |
| 42 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.84742185 |
| 43 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.77822526 |
| 44 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.74849091 |
| 45 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.73854530 |
| 46 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.71506534 |
| 47 | P300_19829295_ChIP-Seq_ESCs_Human | 1.70793624 |
| 48 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.62848770 |
| 49 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60586734 |
| 50 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.57744352 |
| 51 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.56906304 |
| 52 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.56328694 |
| 53 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.55491798 |
| 54 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.54589519 |
| 55 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.49519912 |
| 56 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.43024555 |
| 57 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.41171091 |
| 58 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.39398215 |
| 59 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.37570792 |
| 60 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.37358765 |
| 61 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.36523759 |
| 62 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.35425290 |
| 63 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.32260587 |
| 64 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.30499595 |
| 65 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.30436465 |
| 66 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.28151335 |
| 67 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.28130624 |
| 68 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.27804144 |
| 69 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.24625275 |
| 70 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24491802 |
| 71 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.22975145 |
| 72 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.22410333 |
| 73 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.22400213 |
| 74 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.21062937 |
| 75 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.20724412 |
| 76 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.20283935 |
| 77 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.19649232 |
| 78 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.17088424 |
| 79 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.16169984 |
| 80 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.14825513 |
| 81 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.14559121 |
| 82 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.12077740 |
| 83 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.11749731 |
| 84 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.11297909 |
| 85 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.11297909 |
| 86 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.11163453 |
| 87 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.10270744 |
| 88 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.09967347 |
| 89 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.09642284 |
| 90 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.09223649 |
| 91 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.09187101 |
| 92 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.09103390 |
| 93 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.08864675 |
| 94 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.08858184 |
| 95 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.08817320 |
| 96 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08622608 |
| 97 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.06979260 |
| 98 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.05712506 |
| 99 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.04425672 |
| 100 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.03456784 |
| 101 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.03456784 |
| 102 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.02839004 |
| 103 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.01983436 |
| 104 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01640193 |
| 105 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.00922928 |
| 106 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.00907443 |
| 107 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.00367160 |
| 108 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99297524 |
| 109 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99265465 |
| 110 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.98899018 |
| 111 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.98899018 |
| 112 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.98344465 |
| 113 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.98092292 |
| 114 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.97810496 |
| 115 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.97732983 |
| 116 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97116896 |
| 117 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.96682032 |
| 118 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.96495624 |
| 119 | * POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.95700398 |
| 120 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.95439389 |
| 121 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.94977000 |
| 122 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.94913904 |
| 123 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94336695 |
| 124 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.94079742 |
| 125 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.93929974 |
| 126 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.93305900 |
| 127 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.92663833 |
| 128 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.91330205 |
| 129 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.91330205 |
| 130 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.90972219 |
| 131 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.90786229 |
| 132 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.90453012 |
| 133 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.88563669 |
| 134 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.86989209 |
| 135 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.86552385 |
| 136 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.86544172 |
| 137 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.85808702 |
| 138 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85224027 |
| 139 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.84828516 |
| 140 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84082193 |
| 141 | AR_20517297_ChIP-Seq_VCAP_Human | 0.83399316 |
| 142 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.81979473 |
| 143 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81657821 |
| 144 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.79651493 |
| 145 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.79403249 |
| 146 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79159661 |
| 147 | GATA3_26560356_Chip-Seq_TH2_Human | 0.79039457 |
| 148 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.78716424 |
| 149 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.78362873 |
| 150 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78157392 |
| 151 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.77461105 |
| 152 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.76949583 |
| 153 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.76253190 |
| 154 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.73975809 |
| 155 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.73905734 |
| 156 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.73452170 |
| 157 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.72640844 |
| 158 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.72586877 |
| 159 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.72553869 |
| 160 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.71479156 |
| 161 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.71281907 |
| 162 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.70354872 |
| 163 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.69660788 |
| 164 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69068266 |
| 165 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.68713902 |
| 166 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.67601823 |
| 167 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.67253580 |
| 168 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.67048867 |
| 169 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.65545810 |
| 170 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.65203612 |
| 171 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.64192119 |
| 172 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.64074625 |
| 173 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.63752470 |
| 174 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.63217568 |
| 175 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.63018235 |
| 176 | * PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.62384424 |
| 177 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.61643425 |
| 178 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.60873498 |
| 179 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.60814664 |
| 180 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.59734210 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.65249407 |
| 2 | MP0005360_urolithiasis | 5.33058351 |
| 3 | MP0005365_abnormal_bile_salt | 4.91054611 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.86352904 |
| 5 | MP0008058_abnormal_DNA_repair | 3.92054059 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.84531863 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.65802559 |
| 8 | MP0003195_calcinosis | 3.61878674 |
| 9 | MP0003252_abnormal_bile_duct | 3.22239607 |
| 10 | MP0010094_abnormal_chromosome_stability | 3.07431827 |
| 11 | MP0002102_abnormal_ear_morphology | 2.87986327 |
| 12 | MP0009840_abnormal_foam_cell | 2.85763568 |
| 13 | MP0010329_abnormal_lipoprotein_level | 2.65322482 |
| 14 | MP0008877_abnormal_DNA_methylation | 2.64639764 |
| 15 | MP0005083_abnormal_biliary_tract | 2.55660361 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.46027346 |
| 17 | MP0000372_irregular_coat_pigmentation | 2.45505912 |
| 18 | MP0002938_white_spotting | 2.38453406 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.37722608 |
| 20 | MP0005332_abnormal_amino_acid | 2.32685427 |
| 21 | MP0003693_abnormal_embryo_hatching | 2.30317409 |
| 22 | MP0004957_abnormal_blastocyst_morpholog | 2.29707179 |
| 23 | MP0001666_abnormal_nutrient_absorption | 2.28802644 |
| 24 | MP0008007_abnormal_cellular_replicative | 2.20744835 |
| 25 | MP0003786_premature_aging | 2.18612406 |
| 26 | MP0001529_abnormal_vocalization | 2.18362354 |
| 27 | MP0000516_abnormal_urinary_system | 2.13077708 |
| 28 | MP0005367_renal/urinary_system_phenotyp | 2.13077708 |
| 29 | MP0003718_maternal_effect | 2.08070731 |
| 30 | MP0003880_abnormal_central_pattern | 2.00749624 |
| 31 | MP0006072_abnormal_retinal_apoptosis | 1.99571470 |
| 32 | MP0003186_abnormal_redox_activity | 1.91404814 |
| 33 | MP0000609_abnormal_liver_physiology | 1.86824469 |
| 34 | MP0003950_abnormal_plasma_membrane | 1.83041224 |
| 35 | MP0008932_abnormal_embryonic_tissue | 1.82632371 |
| 36 | MP0000569_abnormal_digit_pigmentation | 1.82289261 |
| 37 | MP0003111_abnormal_nucleus_morphology | 1.81701415 |
| 38 | MP0002118_abnormal_lipid_homeostasis | 1.80792137 |
| 39 | MP0003724_increased_susceptibility_to | 1.78471446 |
| 40 | MP0008789_abnormal_olfactory_epithelium | 1.77684740 |
| 41 | MP0002277_abnormal_respiratory_mucosa | 1.75332444 |
| 42 | MP0003868_abnormal_feces_composition | 1.74611139 |
| 43 | MP0004019_abnormal_vitamin_homeostasis | 1.72232934 |
| 44 | MP0005058_abnormal_lysosome_morphology | 1.71626053 |
| 45 | MP0003077_abnormal_cell_cycle | 1.69960638 |
| 46 | MP0001764_abnormal_homeostasis | 1.68630336 |
| 47 | MP0003890_abnormal_embryonic-extraembry | 1.65863371 |
| 48 | MP0005253_abnormal_eye_physiology | 1.65376038 |
| 49 | MP0002736_abnormal_nociception_after | 1.60141141 |
| 50 | MP0003941_abnormal_skin_development | 1.59294410 |
| 51 | MP0009643_abnormal_urine_homeostasis | 1.59147839 |
| 52 | MP0006035_abnormal_mitochondrial_morpho | 1.58988790 |
| 53 | MP0004147_increased_porphyrin_level | 1.57199428 |
| 54 | MP0005319_abnormal_enzyme/_coenzyme | 1.56564879 |
| 55 | MP0005220_abnormal_exocrine_pancreas | 1.53275235 |
| 56 | MP0001835_abnormal_antigen_presentation | 1.51942162 |
| 57 | MP0006292_abnormal_olfactory_placode | 1.50400451 |
| 58 | MP0003436_decreased_susceptibility_to | 1.48792068 |
| 59 | MP0002090_abnormal_vision | 1.47975585 |
| 60 | MP0004133_heterotaxia | 1.47609581 |
| 61 | MP0005408_hypopigmentation | 1.43788001 |
| 62 | MP0005451_abnormal_body_composition | 1.43409945 |
| 63 | MP0009697_abnormal_copulation | 1.42055605 |
| 64 | MP0002876_abnormal_thyroid_physiology | 1.41723022 |
| 65 | MP0005551_abnormal_eye_electrophysiolog | 1.41521115 |
| 66 | MP0004782_abnormal_surfactant_physiolog | 1.38487872 |
| 67 | MP0002751_abnormal_autonomic_nervous | 1.38240733 |
| 68 | MP0001293_anophthalmia | 1.36826960 |
| 69 | MP0003567_abnormal_fetal_cardiomyocyte | 1.35106451 |
| 70 | MP0008057_abnormal_DNA_replication | 1.34079607 |
| 71 | MP0003136_yellow_coat_color | 1.32879523 |
| 72 | MP0008469_abnormal_protein_level | 1.32677514 |
| 73 | MP0008872_abnormal_physiological_respon | 1.29023796 |
| 74 | MP0009785_altered_susceptibility_to | 1.27984439 |
| 75 | MP0006082_CNS_inflammation | 1.25933592 |
| 76 | MP0009764_decreased_sensitivity_to | 1.25420569 |
| 77 | MP0002693_abnormal_pancreas_physiology | 1.24922794 |
| 78 | MP0004215_abnormal_myocardial_fiber | 1.24587388 |
| 79 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.24546618 |
| 80 | MP0001984_abnormal_olfaction | 1.21712911 |
| 81 | MP0002419_abnormal_innate_immunity | 1.17065884 |
| 82 | MP0005084_abnormal_gallbladder_morpholo | 1.14852723 |
| 83 | MP0005636_abnormal_mineral_homeostasis | 1.11810613 |
| 84 | MP0001485_abnormal_pinna_reflex | 1.10787053 |
| 85 | MP0005379_endocrine/exocrine_gland_phen | 1.10601021 |
| 86 | MP0002233_abnormal_nose_morphology | 1.10535690 |
| 87 | MP0002148_abnormal_hypersensitivity_rea | 1.09993235 |
| 88 | MP0002282_abnormal_trachea_morphology | 1.09524368 |
| 89 | MP0004043_abnormal_pH_regulation | 1.09467947 |
| 90 | MP0003011_delayed_dark_adaptation | 1.08957244 |
| 91 | MP0000358_abnormal_cell_content/ | 1.08867900 |
| 92 | MP0005025_abnormal_response_to | 1.08745115 |
| 93 | MP0009763_increased_sensitivity_to | 1.08661416 |
| 94 | MP0005174_abnormal_tail_pigmentation | 1.08642585 |
| 95 | MP0003937_abnormal_limbs/digits/tail_de | 1.08362617 |
| 96 | MP0005387_immune_system_phenotype | 1.07869838 |
| 97 | MP0001790_abnormal_immune_system | 1.07869838 |
| 98 | MP0001661_extended_life_span | 1.07553094 |
| 99 | MP0005075_abnormal_melanosome_morpholog | 1.06317223 |
| 100 | MP0003656_abnormal_erythrocyte_physiolo | 1.05233396 |
| 101 | MP0000598_abnormal_liver_morphology | 1.04342860 |
| 102 | MP0002078_abnormal_glucose_homeostasis | 1.03929676 |
| 103 | MP0002638_abnormal_pupillary_reflex | 1.03800803 |
| 104 | MP0002095_abnormal_skin_pigmentation | 1.03087046 |
| 105 | MP0005671_abnormal_response_to | 1.02957427 |
| 106 | MP0003121_genomic_imprinting | 1.02757457 |
| 107 | MP0001944_abnormal_pancreas_morphology | 1.01368318 |
| 108 | MP0005394_taste/olfaction_phenotype | 1.00328581 |
| 109 | MP0005499_abnormal_olfactory_system | 1.00328581 |
| 110 | MP0002837_dystrophic_cardiac_calcinosis | 0.99807665 |
| 111 | MP0000647_abnormal_sebaceous_gland | 0.99780059 |
| 112 | MP0001324_abnormal_eye_pigmentation | 0.98065687 |
| 113 | MP0002877_abnormal_melanocyte_morpholog | 0.96589912 |
| 114 | MP0001845_abnormal_inflammatory_respons | 0.95485837 |
| 115 | MP0005000_abnormal_immune_tolerance | 0.93894019 |
| 116 | MP0009642_abnormal_blood_homeostasis | 0.92902779 |
| 117 | MP0000427_abnormal_hair_cycle | 0.92329194 |
| 118 | MP0005464_abnormal_platelet_physiology | 0.90905215 |
| 119 | MP0002163_abnormal_gland_morphology | 0.90319017 |
| 120 | MP0001188_hyperpigmentation | 0.90270219 |
| 121 | MP0001119_abnormal_female_reproductive | 0.90087435 |
| 122 | MP0000685_abnormal_immune_system | 0.88138402 |
| 123 | MP0001756_abnormal_urination | 0.88011901 |
| 124 | MP0000604_amyloidosis | 0.87587569 |
| 125 | MP0005647_abnormal_sex_gland | 0.87341484 |
| 126 | MP0002234_abnormal_pharynx_morphology | 0.87079691 |
| 127 | MP0004381_abnormal_hair_follicle | 0.84703724 |
| 128 | MP0001286_abnormal_eye_development | 0.83208422 |
| 129 | MP0001929_abnormal_gametogenesis | 0.81987573 |
| 130 | MP0001533_abnormal_skeleton_physiology | 0.81952613 |
| 131 | MP0001177_atelectasis | 0.79850983 |
| 132 | MP0003755_abnormal_palate_morphology | 0.79725614 |
| 133 | MP0003183_abnormal_peptide_metabolism | 0.79267689 |
| 134 | MP0004142_abnormal_muscle_tone | 0.78726109 |
| 135 | MP0005391_vision/eye_phenotype | 0.77271940 |
| 136 | MP0009765_abnormal_xenobiotic_induced | 0.75808558 |
| 137 | MP0002723_abnormal_immune_serum | 0.75507367 |
| 138 | MP0002254_reproductive_system_inflammat | 0.75391372 |
| 139 | MP0002928_abnormal_bile_duct | 0.72780617 |
| 140 | MP0000653_abnormal_sex_gland | 0.71996950 |
| 141 | MP0005389_reproductive_system_phenotype | 0.71870199 |
| 142 | MP0010386_abnormal_urinary_bladder | 0.71467390 |
| 143 | MP0003690_abnormal_glial_cell | 0.70767003 |
| 144 | MP0001800_abnormal_humoral_immune | 0.70323098 |
| 145 | MP0001853_heart_inflammation | 0.69977326 |
| 146 | MP0006036_abnormal_mitochondrial_physio | 0.69801184 |
| 147 | MP0005171_absent_coat_pigmentation | 0.69743376 |
| 148 | MP0002210_abnormal_sex_determination | 0.68583184 |
| 149 | MP0008995_early_reproductive_senescence | 0.67743447 |
| 150 | MP0005334_abnormal_fat_pad | 0.67577660 |
| 151 | MP0002295_abnormal_pulmonary_circulatio | 0.67374705 |
| 152 | MP0005376_homeostasis/metabolism_phenot | 0.67222077 |
| 153 | MP0008873_increased_physiological_sensi | 0.66954074 |
| 154 | MP0002452_abnormal_antigen_presenting | 0.66305564 |
| 155 | MP0005195_abnormal_posterior_eye | 0.66285448 |
| 156 | MP0002136_abnormal_kidney_physiology | 0.65511572 |
| 157 | MP0002166_altered_tumor_susceptibility | 0.64035493 |
| 158 | MP0003119_abnormal_digestive_system | 0.63739632 |
| 159 | MP0001145_abnormal_male_reproductive | 0.62445036 |
| 160 | MP0003137_abnormal_impulse_conducting | 0.61344269 |
| 161 | MP0001542_abnormal_bone_strength | 0.59755911 |
| 162 | MP0006054_spinal_hemorrhage | 0.58755106 |
| 163 | MP0005395_other_phenotype | 0.58581072 |
| 164 | MP0004947_skin_inflammation | 0.57657235 |
| 165 | MP0003172_abnormal_lysosome_physiology | 0.57049633 |
| 166 | MP0005535_abnormal_body_temperature | 0.56021831 |
| 167 | MP0004264_abnormal_extraembryonic_tissu | 0.55436388 |
| 168 | MP0001243_abnormal_dermal_layer | 0.54643317 |
| 169 | MP0008260_abnormal_autophagy | 0.53731162 |
| 170 | MP0000613_abnormal_salivary_gland | 0.53669259 |
| 171 | MP0001819_abnormal_immune_cell | 0.52994230 |
| 172 | MP0002132_abnormal_respiratory_system | 0.52926864 |
| 173 | MP0002420_abnormal_adaptive_immunity | 0.51961297 |
| 174 | MP0005310_abnormal_salivary_gland | 0.51691795 |
| 175 | MP0002971_abnormal_brown_adipose | 0.51335142 |
| 176 | MP0003300_gastrointestinal_ulcer | 0.50623291 |
| 177 | MP0003953_abnormal_hormone_level | 0.50503924 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.30727011 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.62818504 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 5.59550133 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.92753978 |
| 5 | Deep venous thrombosis (HP:0002625) | 4.88485282 |
| 6 | Hypoglycemic coma (HP:0001325) | 4.83207577 |
| 7 | Xanthomatosis (HP:0000991) | 4.68466759 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 4.46681148 |
| 9 | Joint hemorrhage (HP:0005261) | 4.18246214 |
| 10 | Abnormality of the common coagulation pathway (HP:0010990) | 4.06608652 |
| 11 | Complement deficiency (HP:0004431) | 4.04566903 |
| 12 | Conjugated hyperbilirubinemia (HP:0002908) | 4.04206038 |
| 13 | Acute necrotizing encephalopathy (HP:0006965) | 4.01437897 |
| 14 | Abnormality of the intrinsic pathway (HP:0010989) | 3.98025737 |
| 15 | Hyperlipoproteinemia (HP:0010980) | 3.92793535 |
| 16 | Hypoglycemic seizures (HP:0002173) | 3.85516616 |
| 17 | Fat malabsorption (HP:0002630) | 3.65094868 |
| 18 | Mitochondrial inheritance (HP:0001427) | 3.62046228 |
| 19 | Hyperglycinemia (HP:0002154) | 3.59069239 |
| 20 | Acute encephalopathy (HP:0006846) | 3.50110444 |
| 21 | Increased CSF lactate (HP:0002490) | 3.48705590 |
| 22 | Generalized aminoaciduria (HP:0002909) | 3.47255091 |
| 23 | Ketosis (HP:0001946) | 3.43831546 |
| 24 | Abnormality of methionine metabolism (HP:0010901) | 3.42928569 |
| 25 | Progressive macrocephaly (HP:0004481) | 3.41683803 |
| 26 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.39281006 |
| 27 | Pancreatic cysts (HP:0001737) | 3.32785152 |
| 28 | Hypolipoproteinemia (HP:0010981) | 3.32684796 |
| 29 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.32612384 |
| 30 | Epidermoid cyst (HP:0200040) | 3.24844461 |
| 31 | Methylmalonic acidemia (HP:0002912) | 3.23653858 |
| 32 | Abnormality of complement system (HP:0005339) | 3.21735039 |
| 33 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.21458729 |
| 34 | Symptomatic seizures (HP:0011145) | 3.18032356 |
| 35 | Hyperammonemia (HP:0001987) | 3.16759112 |
| 36 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.12241835 |
| 37 | Hepatocellular necrosis (HP:0001404) | 3.11559697 |
| 38 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.10193861 |
| 39 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.08927779 |
| 40 | Increased hepatocellular lipid droplets (HP:0006565) | 3.08884321 |
| 41 | True hermaphroditism (HP:0010459) | 3.07990758 |
| 42 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.06301354 |
| 43 | Abnormality of midbrain morphology (HP:0002418) | 3.06164244 |
| 44 | Molar tooth sign on MRI (HP:0002419) | 3.06164244 |
| 45 | Systemic lupus erythematosus (HP:0002725) | 3.05628292 |
| 46 | Vacuolated lymphocytes (HP:0001922) | 3.05132542 |
| 47 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.03258396 |
| 48 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.02417995 |
| 49 | Abnormality of glycine metabolism (HP:0010895) | 3.01559390 |
| 50 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.01559390 |
| 51 | Ketoacidosis (HP:0001993) | 2.94467372 |
| 52 | Colon cancer (HP:0003003) | 2.92886690 |
| 53 | Abnormality of the labia minora (HP:0012880) | 2.92099037 |
| 54 | Steatorrhea (HP:0002570) | 2.91816872 |
| 55 | Pancreatic fibrosis (HP:0100732) | 2.90006469 |
| 56 | Hyperglycinuria (HP:0003108) | 2.88682241 |
| 57 | Type I transferrin isoform profile (HP:0003642) | 2.87915665 |
| 58 | Meckel diverticulum (HP:0002245) | 2.86746029 |
| 59 | Hypoalphalipoproteinemia (HP:0003233) | 2.85589186 |
| 60 | Myocardial infarction (HP:0001658) | 2.83494657 |
| 61 | Hyperbilirubinemia (HP:0002904) | 2.83090036 |
| 62 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.80212940 |
| 63 | Abnormality of chromosome stability (HP:0003220) | 2.78811817 |
| 64 | Hepatic necrosis (HP:0002605) | 2.77377943 |
| 65 | 3-Methylglutaconic aciduria (HP:0003535) | 2.76561499 |
| 66 | Abnormality of the ileum (HP:0001549) | 2.75843355 |
| 67 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.73036943 |
| 68 | Glomerulonephritis (HP:0000099) | 2.70428086 |
| 69 | Dicarboxylic aciduria (HP:0003215) | 2.66946134 |
| 70 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.66946134 |
| 71 | Lipid accumulation in hepatocytes (HP:0006561) | 2.65468754 |
| 72 | Hypercholesterolemia (HP:0003124) | 2.57231033 |
| 73 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.54418353 |
| 74 | Increased serum lactate (HP:0002151) | 2.51624560 |
| 75 | Abnormality of nucleobase metabolism (HP:0010932) | 2.51389036 |
| 76 | Renal Fanconi syndrome (HP:0001994) | 2.47889075 |
| 77 | Abnormality of serum amino acid levels (HP:0003112) | 2.45981315 |
| 78 | Medial flaring of the eyebrow (HP:0010747) | 2.42080536 |
| 79 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.40900828 |
| 80 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.40900828 |
| 81 | Abnormality of purine metabolism (HP:0004352) | 2.40565082 |
| 82 | Abnormality of the preputium (HP:0100587) | 2.39941675 |
| 83 | Hyperglycemia (HP:0003074) | 2.39742082 |
| 84 | Bifid tongue (HP:0010297) | 2.38739934 |
| 85 | Congenital, generalized hypertrichosis (HP:0004540) | 2.36820617 |
| 86 | Renal cortical cysts (HP:0000803) | 2.31992251 |
| 87 | Intestinal atresia (HP:0011100) | 2.31653105 |
| 88 | Lactic acidosis (HP:0003128) | 2.30736981 |
| 89 | Reduced antithrombin III activity (HP:0001976) | 2.30557424 |
| 90 | Delayed CNS myelination (HP:0002188) | 2.29689222 |
| 91 | Lethargy (HP:0001254) | 2.27548000 |
| 92 | Pancreatitis (HP:0001733) | 2.27408870 |
| 93 | Abnormality of urine glucose concentration (HP:0011016) | 2.26410862 |
| 94 | Glycosuria (HP:0003076) | 2.26410862 |
| 95 | Opisthotonus (HP:0002179) | 2.25484416 |
| 96 | Late onset (HP:0003584) | 2.24240127 |
| 97 | Metabolic acidosis (HP:0001942) | 2.22431678 |
| 98 | Mitral stenosis (HP:0001718) | 2.22359777 |
| 99 | Progressive inability to walk (HP:0002505) | 2.21386795 |
| 100 | Hepatocellular carcinoma (HP:0001402) | 2.20940321 |
| 101 | Vascular calcification (HP:0004934) | 2.20336373 |
| 102 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.18434495 |
| 103 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.17606367 |
| 104 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.16573922 |
| 105 | Abnormality of alanine metabolism (HP:0010916) | 2.16280036 |
| 106 | Hyperalaninemia (HP:0003348) | 2.16280036 |
| 107 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.16280036 |
| 108 | Optic disc pallor (HP:0000543) | 2.13129732 |
| 109 | Nephronophthisis (HP:0000090) | 2.12807562 |
| 110 | Elevated alkaline phosphatase (HP:0003155) | 2.12655859 |
| 111 | Hypoplastic pelvis (HP:0008839) | 2.12180018 |
| 112 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.10633959 |
| 113 | Irritability (HP:0000737) | 2.09490223 |
| 114 | Abnormal lung lobation (HP:0002101) | 2.09472341 |
| 115 | Gingival bleeding (HP:0000225) | 2.08363877 |
| 116 | Recurrent bacterial skin infections (HP:0005406) | 2.08359647 |
| 117 | Cerebral edema (HP:0002181) | 2.08122724 |
| 118 | Abnormality of vitamin B metabolism (HP:0004340) | 2.07761363 |
| 119 | Small intestinal stenosis (HP:0012848) | 2.06783368 |
| 120 | Duodenal stenosis (HP:0100867) | 2.06783368 |
| 121 | Nephrogenic diabetes insipidus (HP:0009806) | 2.06045146 |
| 122 | Skin nodule (HP:0200036) | 2.05781920 |
| 123 | Exertional dyspnea (HP:0002875) | 2.05448652 |
| 124 | Stenosis of the external auditory canal (HP:0000402) | 2.05117054 |
| 125 | Hypothermia (HP:0002045) | 2.04438232 |
| 126 | Chromsome breakage (HP:0040012) | 2.04156480 |
| 127 | Sclerocornea (HP:0000647) | 2.02999362 |
| 128 | Respiratory failure (HP:0002878) | 2.01385157 |
| 129 | Abnormality of the duodenum (HP:0002246) | 2.00922173 |
| 130 | Abolished electroretinogram (ERG) (HP:0000550) | 2.00805311 |
| 131 | Brushfield spots (HP:0001088) | 2.00590630 |
| 132 | Mucopolysacchariduria (HP:0008155) | 1.99499578 |
| 133 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.99499578 |
| 134 | Congenital primary aphakia (HP:0007707) | 1.99167677 |
| 135 | Proximal tubulopathy (HP:0000114) | 1.95409681 |
| 136 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.95360546 |
| 137 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.95261131 |
| 138 | Anencephaly (HP:0002323) | 1.93609672 |
| 139 | Postaxial foot polydactyly (HP:0001830) | 1.92785186 |
| 140 | Sloping forehead (HP:0000340) | 1.92726322 |
| 141 | Menorrhagia (HP:0000132) | 1.92698407 |
| 142 | Epiphyseal stippling (HP:0010655) | 1.92159802 |
| 143 | Prolonged neonatal jaundice (HP:0006579) | 1.91648634 |
| 144 | Cardiovascular calcification (HP:0011915) | 1.90908408 |
| 145 | Abnormality of the renal cortex (HP:0011035) | 1.87916078 |
| 146 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.87852643 |
| 147 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.87852643 |
| 148 | Abnormality of placental membranes (HP:0011409) | 1.87481348 |
| 149 | Amniotic constriction ring (HP:0009775) | 1.87481348 |
| 150 | Dysostosis multiplex (HP:0000943) | 1.86922713 |
| 151 | Elevated hepatic transaminases (HP:0002910) | 1.86847202 |
| 152 | Oligodactyly (hands) (HP:0001180) | 1.85724414 |
| 153 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.84914919 |
| 154 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.84914919 |
| 155 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.84914919 |
| 156 | Genital tract atresia (HP:0001827) | 1.84576740 |
| 157 | Acute hepatic failure (HP:0006554) | 1.84246942 |
| 158 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.84223169 |
| 159 | Small hand (HP:0200055) | 1.82333792 |
| 160 | Vomiting (HP:0002013) | 1.82220644 |
| 161 | Gait imbalance (HP:0002141) | 1.81850359 |
| 162 | Leukodystrophy (HP:0002415) | 1.81610008 |
| 163 | Volvulus (HP:0002580) | 1.81404123 |
| 164 | Amyloidosis (HP:0011034) | 1.81003859 |
| 165 | Agnosia (HP:0010524) | 1.80867742 |
| 166 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.80048171 |
| 167 | Methylmalonic aciduria (HP:0012120) | 1.80027124 |
| 168 | Eczematoid dermatitis (HP:0000976) | 1.79982688 |
| 169 | CNS demyelination (HP:0007305) | 1.79971755 |
| 170 | Abnormality of the renal medulla (HP:0100957) | 1.78888383 |
| 171 | Preaxial hand polydactyly (HP:0001177) | 1.78262052 |
| 172 | Vaginal atresia (HP:0000148) | 1.78223966 |
| 173 | Hypoproteinemia (HP:0003075) | 1.77780784 |
| 174 | Enlarged kidneys (HP:0000105) | 1.77762273 |
| 175 | Abnormal gallbladder morphology (HP:0012437) | 1.77006137 |
| 176 | Recurrent abscess formation (HP:0002722) | 1.76758492 |
| 177 | Postaxial hand polydactyly (HP:0001162) | 1.76592052 |
| 178 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.75788925 |
| 179 | Abnormal protein glycosylation (HP:0012346) | 1.75788925 |
| 180 | Abnormal glycosylation (HP:0012345) | 1.75788925 |
| 181 | Increased serum pyruvate (HP:0003542) | 1.75535247 |
| 182 | Thyroiditis (HP:0100646) | 1.73603817 |
| 183 | Carpal bone hypoplasia (HP:0001498) | 1.73541064 |
| 184 | Triphalangeal thumb (HP:0001199) | 1.72382435 |
| 185 | Male pseudohermaphroditism (HP:0000037) | 1.71919471 |
| 186 | Dandy-Walker malformation (HP:0001305) | 1.71323892 |
| 187 | Pendular nystagmus (HP:0012043) | 1.71002464 |
| 188 | Clubbing of toes (HP:0100760) | 1.70937474 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.02477910 |
| 2 | INSRR | 3.91872228 |
| 3 | BUB1 | 3.54474672 |
| 4 | PBK | 3.43519354 |
| 5 | ERN1 | 3.29031786 |
| 6 | TAOK3 | 3.12268158 |
| 7 | IRAK3 | 3.10358753 |
| 8 | TRIM28 | 3.07349711 |
| 9 | MAP3K14 | 2.89071557 |
| 10 | VRK2 | 2.70152524 |
| 11 | FGFR4 | 2.67904398 |
| 12 | WNK3 | 2.66649521 |
| 13 | IRAK4 | 2.65107184 |
| 14 | MAP4K2 | 2.43577037 |
| 15 | MKNK2 | 2.36449322 |
| 16 | NEK9 | 2.06269330 |
| 17 | TYK2 | 2.06097045 |
| 18 | SRPK1 | 2.01730763 |
| 19 | NEK1 | 1.97716846 |
| 20 | PLK3 | 1.97284869 |
| 21 | MKNK1 | 1.93992422 |
| 22 | TBK1 | 1.90666157 |
| 23 | PLK4 | 1.87321458 |
| 24 | FRK | 1.84071608 |
| 25 | MAPK15 | 1.82439831 |
| 26 | PIK3CG | 1.80922338 |
| 27 | TNIK | 1.79454156 |
| 28 | WEE1 | 1.79336855 |
| 29 | VRK1 | 1.78546308 |
| 30 | EIF2AK3 | 1.76540346 |
| 31 | FLT3 | 1.75233850 |
| 32 | IRAK1 | 1.74912988 |
| 33 | TSSK6 | 1.69792829 |
| 34 | ERBB3 | 1.69695178 |
| 35 | STK16 | 1.66465959 |
| 36 | JAK3 | 1.63951520 |
| 37 | TXK | 1.63758174 |
| 38 | SIK1 | 1.61836315 |
| 39 | IKBKE | 1.58038145 |
| 40 | BLK | 1.55240267 |
| 41 | PDK2 | 1.47407411 |
| 42 | TAF1 | 1.46768855 |
| 43 | NLK | 1.44453133 |
| 44 | PASK | 1.44452809 |
| 45 | MST4 | 1.40322764 |
| 46 | EPHA3 | 1.39109497 |
| 47 | JAK1 | 1.36391247 |
| 48 | MAP3K12 | 1.33241125 |
| 49 | TEC | 1.32942016 |
| 50 | EPHB1 | 1.31190815 |
| 51 | NUAK1 | 1.25386531 |
| 52 | PLK2 | 1.25169983 |
| 53 | ERBB4 | 1.23917071 |
| 54 | IRAK2 | 1.18402112 |
| 55 | NME2 | 1.18063010 |
| 56 | CDC7 | 1.18018269 |
| 57 | MAP4K1 | 1.17794518 |
| 58 | TTK | 1.16666999 |
| 59 | PNCK | 1.15688229 |
| 60 | ZAP70 | 1.15093383 |
| 61 | SIK3 | 1.11735777 |
| 62 | KDR | 1.11087114 |
| 63 | CASK | 1.09257167 |
| 64 | CSK | 1.08200497 |
| 65 | IKBKB | 1.06665187 |
| 66 | PLK1 | 1.04242061 |
| 67 | ABL2 | 1.01551181 |
| 68 | MST1R | 1.01129468 |
| 69 | BMPR1B | 0.92491227 |
| 70 | CCNB1 | 0.91431146 |
| 71 | MET | 0.91389092 |
| 72 | EIF2AK1 | 0.87268836 |
| 73 | DYRK2 | 0.85874986 |
| 74 | ITK | 0.85498562 |
| 75 | TGFBR1 | 0.85232162 |
| 76 | BMPR2 | 0.83763521 |
| 77 | OXSR1 | 0.83628682 |
| 78 | MAPK13 | 0.80879486 |
| 79 | JAK2 | 0.80877128 |
| 80 | PAK3 | 0.80176832 |
| 81 | WNK4 | 0.79784515 |
| 82 | PIM2 | 0.79672758 |
| 83 | CSNK1G2 | 0.77645423 |
| 84 | CHUK | 0.77163207 |
| 85 | NME1 | 0.75476707 |
| 86 | BTK | 0.75415231 |
| 87 | LYN | 0.74403723 |
| 88 | MAPK11 | 0.72606725 |
| 89 | YES1 | 0.72398628 |
| 90 | PRKCQ | 0.71666842 |
| 91 | DYRK1B | 0.71642216 |
| 92 | GRK1 | 0.69946979 |
| 93 | EPHA2 | 0.69764585 |
| 94 | KIT | 0.69010538 |
| 95 | MAP2K7 | 0.66914298 |
| 96 | NEK6 | 0.66157889 |
| 97 | EIF2AK2 | 0.65247146 |
| 98 | MAP3K4 | 0.64474776 |
| 99 | HIPK2 | 0.63719293 |
| 100 | EPHA4 | 0.63332941 |
| 101 | BRSK1 | 0.63282927 |
| 102 | FGFR2 | 0.62731655 |
| 103 | PTK6 | 0.59724554 |
| 104 | AURKB | 0.58493810 |
| 105 | STK3 | 0.58373496 |
| 106 | ATR | 0.58218237 |
| 107 | BCR | 0.58100339 |
| 108 | TLK1 | 0.57635329 |
| 109 | MYLK | 0.56476887 |
| 110 | FGFR3 | 0.55637235 |
| 111 | LCK | 0.55075759 |
| 112 | STK38L | 0.54281954 |
| 113 | MAP3K3 | 0.52325846 |
| 114 | ACVR1B | 0.52251665 |
| 115 | SYK | 0.51905063 |
| 116 | ADRBK2 | 0.51196328 |
| 117 | IGF1R | 0.50721724 |
| 118 | CAMKK2 | 0.48016723 |
| 119 | CHEK2 | 0.46934054 |
| 120 | ATM | 0.46805612 |
| 121 | TESK2 | 0.46636445 |
| 122 | GRK7 | 0.45780024 |
| 123 | CSNK2A1 | 0.44741248 |
| 124 | CSF1R | 0.44535724 |
| 125 | PKN1 | 0.43494306 |
| 126 | DAPK1 | 0.43041522 |
| 127 | MAP2K2 | 0.42763534 |
| 128 | PRKCG | 0.42696883 |
| 129 | ZAK | 0.42498603 |
| 130 | LIMK1 | 0.41814771 |
| 131 | PRKCD | 0.41570526 |
| 132 | CSNK1A1L | 0.41568927 |
| 133 | STK4 | 0.41244053 |
| 134 | STK39 | 0.39293097 |
| 135 | TIE1 | 0.38780435 |
| 136 | FGFR1 | 0.38619251 |
| 137 | ABL1 | 0.38614621 |
| 138 | ADRBK1 | 0.38538679 |
| 139 | CSNK1G1 | 0.38187163 |
| 140 | PIK3CA | 0.36813818 |
| 141 | LATS1 | 0.36248843 |
| 142 | PIM1 | 0.35235924 |
| 143 | MINK1 | 0.34811287 |
| 144 | RPS6KA4 | 0.33855208 |
| 145 | CSNK2A2 | 0.33631445 |
| 146 | PINK1 | 0.33540185 |
| 147 | BRSK2 | 0.33442900 |
| 148 | GSK3A | 0.33339790 |
| 149 | AKT3 | 0.32789350 |
| 150 | STK10 | 0.32596667 |
| 151 | TGFBR2 | 0.32390070 |
| 152 | CSNK1A1 | 0.31338739 |
| 153 | CSNK1G3 | 0.29806421 |
| 154 | MUSK | 0.29033784 |
| 155 | EPHB2 | 0.29014526 |
| 156 | MAP3K1 | 0.27973642 |
| 157 | PRKCE | 0.27347479 |
| 158 | RPS6KA5 | 0.26723713 |
| 159 | STK24 | 0.26127494 |
| 160 | MARK3 | 0.25945055 |
| 161 | DYRK3 | 0.24999967 |
| 162 | FER | 0.24310265 |
| 163 | CHEK1 | 0.23400857 |
| 164 | MELK | 0.22621876 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.73893987 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.97208020 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.94879844 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.74742398 |
| 5 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.68623749 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 2.56003350 |
| 7 | Homologous recombination_Homo sapiens_hsa03440 | 2.52792989 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.52711152 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.50784612 |
| 10 | Protein export_Homo sapiens_hsa03060 | 2.49457016 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.45865201 |
| 12 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.43816892 |
| 13 | RNA polymerase_Homo sapiens_hsa03020 | 2.40838948 |
| 14 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.40336688 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.39996433 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.33028451 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.29194851 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.19194602 |
| 19 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.16393007 |
| 20 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.16375041 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.15467580 |
| 22 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.12742674 |
| 23 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.09714390 |
| 24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.06936277 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.03846974 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 2.03321578 |
| 27 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.99054454 |
| 28 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.99045546 |
| 29 | Basal transcription factors_Homo sapiens_hsa03022 | 1.91430557 |
| 30 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.90833082 |
| 31 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.87588071 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.81934871 |
| 33 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.80938714 |
| 34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.80405718 |
| 35 | DNA replication_Homo sapiens_hsa03030 | 1.78595326 |
| 36 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.77147304 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.76954407 |
| 38 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.75780795 |
| 39 | RNA degradation_Homo sapiens_hsa03018 | 1.73208852 |
| 40 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.72308016 |
| 41 | Huntingtons disease_Homo sapiens_hsa05016 | 1.72088172 |
| 42 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.67618840 |
| 43 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.62775571 |
| 44 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.62337720 |
| 45 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.60561879 |
| 46 | Spliceosome_Homo sapiens_hsa03040 | 1.58439237 |
| 47 | Retinol metabolism_Homo sapiens_hsa00830 | 1.56355743 |
| 48 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.50721398 |
| 49 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.47418041 |
| 50 | Alzheimers disease_Homo sapiens_hsa05010 | 1.46692478 |
| 51 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.44741416 |
| 52 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.41838686 |
| 53 | RNA transport_Homo sapiens_hsa03013 | 1.41656811 |
| 54 | Ribosome_Homo sapiens_hsa03010 | 1.37904764 |
| 55 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.35887923 |
| 56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.35366808 |
| 57 | Base excision repair_Homo sapiens_hsa03410 | 1.33358938 |
| 58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.31783213 |
| 59 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.27839972 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 1.27045336 |
| 61 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.25383409 |
| 62 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.24317575 |
| 63 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.17206548 |
| 64 | Sulfur relay system_Homo sapiens_hsa04122 | 1.08362931 |
| 65 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.04763397 |
| 66 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98597779 |
| 67 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.97842191 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.97551407 |
| 69 | Purine metabolism_Homo sapiens_hsa00230 | 0.96354736 |
| 70 | Cell cycle_Homo sapiens_hsa04110 | 0.96236709 |
| 71 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.94870308 |
| 72 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.91042361 |
| 73 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.88775583 |
| 74 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.86463885 |
| 75 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.85432811 |
| 76 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.83818072 |
| 77 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.83604107 |
| 78 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.79820829 |
| 79 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.79428160 |
| 80 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.77630147 |
| 81 | Lysosome_Homo sapiens_hsa04142 | 0.75485540 |
| 82 | Other glycan degradation_Homo sapiens_hsa00511 | 0.74584761 |
| 83 | Phototransduction_Homo sapiens_hsa04744 | 0.71468134 |
| 84 | Bile secretion_Homo sapiens_hsa04976 | 0.69457001 |
| 85 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.69320214 |
| 86 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.66527259 |
| 87 | Carbon metabolism_Homo sapiens_hsa01200 | 0.65926980 |
| 88 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.63799124 |
| 89 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.63062521 |
| 90 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.61668898 |
| 91 | Metabolic pathways_Homo sapiens_hsa01100 | 0.60531981 |
| 92 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58284121 |
| 93 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.58161242 |
| 94 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.55726885 |
| 95 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.53255140 |
| 96 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.52384162 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.52173991 |
| 98 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.51373290 |
| 99 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.51089828 |
| 100 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.50544928 |
| 101 | Proteasome_Homo sapiens_hsa03050 | 0.47895220 |
| 102 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47291917 |
| 103 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47115946 |
| 104 | Prion diseases_Homo sapiens_hsa05020 | 0.46803186 |
| 105 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.46449462 |
| 106 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.46405106 |
| 107 | Asthma_Homo sapiens_hsa05310 | 0.46238618 |
| 108 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.45041865 |
| 109 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.42990970 |
| 110 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.42979840 |
| 111 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.42391503 |
| 112 | Lysine degradation_Homo sapiens_hsa00310 | 0.42039645 |
| 113 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.41935787 |
| 114 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.40579994 |
| 115 | Legionellosis_Homo sapiens_hsa05134 | 0.40239878 |
| 116 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.36639369 |
| 117 | Allograft rejection_Homo sapiens_hsa05330 | 0.36163497 |
| 118 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.34821393 |
| 119 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.34459128 |
| 120 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.34080139 |
| 121 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.33590333 |
| 122 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.33575612 |
| 123 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.32962691 |
| 124 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.31638668 |
| 125 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.31441181 |
| 126 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.30482620 |
| 127 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.30242380 |
| 128 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.29580137 |
| 129 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.28682617 |
| 130 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.27398922 |
| 131 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.25955855 |
| 132 | Phagosome_Homo sapiens_hsa04145 | 0.25286327 |
| 133 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.25023141 |
| 134 | Pertussis_Homo sapiens_hsa05133 | 0.24770538 |
| 135 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.24411870 |
| 136 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.18638664 |
| 137 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.15510799 |
| 138 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.15502911 |
| 139 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.15165629 |

